Vaxart Inc

Vaxart Inc a clinicalstage biotechnology company engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform The companys product pipeline includes norovirus vaccine an oral tablet vaccine which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI1 and GII4 norovirus strains seasonal influenza vaccine which is in Phase II clinical trial for the treatment of H1 influenza infection respiratory syncytial virus vaccine and coronavirus vaccine which is in Phase II clinical trial for the treatment of SARSCoV2 infection It is also developing therapeutic vaccines for cervical cancer and dysplasia caused by human papillomavirus The company is headquartered in South San Francisco California